These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34619230)

  • 1. The lupus nephritis management renaissance.
    Mejia-Vilet JM; Malvar A; Arazi A; Rovin BH
    Kidney Int; 2022 Feb; 101(2):242-255. PubMed ID: 34619230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kidney Biopsy in Systemic Lupus Erythematosus: A View of the Past and a Vision of the Future.
    Ayoub I; Cassol C; Almaani S; Rovin B; Parikh SV
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):360-368. PubMed ID: 31733720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus Nephritis Biomarkers: A Critical Review.
    Alduraibi FK; Tsokos GC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lupus nephritis].
    Mucke J; Schneider M
    Z Rheumatol; 2023 Feb; 82(1):40-52. PubMed ID: 36063165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
    Parodis I; Tamirou F; Houssiau FA
    Arch Immunol Ther Exp (Warsz); 2022 Feb; 70(1):8. PubMed ID: 35147824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.
    Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M
    Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis.
    Nie H; Chang S; Li Y; Li F
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Lupus Nephritis: An Update.
    Gupta KL; Bharati J
    J Assoc Physicians India; 2022 Mar; 70(3):11-12. PubMed ID: 35438287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
    Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
    Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis.
    Anders HJ; Saxena R; Zhao MH; Parodis I; Salmon JE; Mohan C
    Nat Rev Dis Primers; 2020 Jan; 6(1):7. PubMed ID: 31974366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis.
    Parikh SV; Malvar A; Song H; Shapiro J; Mejia-Vilet JM; Ayoub I; Almaani S; Madhavan S; Alberton V; Besso C; Lococo B; Satoskar A; Zhang J; Yu L; Fadda P; Eadon M; Birmingham D; Ganesan LP; Jarjour W; Rovin BH
    Kidney Int; 2022 Oct; 102(4):845-865. PubMed ID: 35788359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of diagnosis and treatment for lupus nephritis in Spain.
    Moriano C; Bellido-Pastrana D; San Román Gutiérrez C; Rodríguez E
    Nefrologia (Engl Ed); 2023; 43(6):668-675. PubMed ID: 38246809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
    Kostopoulou M; Fanouriakis A; Cheema K; Boletis J; Bertsias G; Jayne D; Boumpas DT
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32699043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus nephritis].
    Melderis S; Wiech T; Iking-Konert C; Steinmetz OM
    Z Rheumatol; 2018 Sep; 77(7):593-608. PubMed ID: 29955955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney biopsy in lupus nephritis: is it still relevant?
    Rovin BH; Parikh SV; Alvarado A
    Rheum Dis Clin North Am; 2014 Aug; 40(3):537-52, ix. PubMed ID: 25034161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.